Ramkrishna Forgings Target Price Halved As UBS Sees Slowing CV Demand, Tariff Woes
UBS has downgraded Ramkrishna Forgings Ltd. to a ‘neutral' rating from its previous ‘buy' recommendation, while sharply cutting the 12-month target price to Rs 680 from Rs 1,500. The downgrade reflects growing concern over a combination of tariff-related headwinds, a weakening global commercial vehicle cycle, and a recent inventory write-off that could significantly affect near-term financial projections.
The global CV cycle outlook has deteriorated, particularly in the North American Class 8 truck segment, which has shown signs of weakness over the past three months, UBS said.
This, combined with tariff-induced supply chain slowdowns, is likely to weigh on Ramkrishna Forgings' revenue performance in the coming quarters. Additionally, the company's high exposure — 75% to CVs and 25% to North America — makes it especially vulnerable to these trends.
While the long-term outlook remains intact — with Indian forging companies expected to gain a greater share of the global market — UBS stresses that medium-term challenges necessitate a more cautious stance. The brokerage has therefore cut its financial year 2026 and fiscal 2027 earnings estimates for Ramkrishna Forgings by 17% and 23% respectively, citing reduced volume visibility and softer-than-expected demand.
The recent one-time inventory discrepancy of Rs 1.5 billion is also flagged as a concern. Though attributed to a lapse in internal verification processes, UBS warns that the impact on investor sentiment and valuation multiples could be significant. The brokerage also notes that the management's inability to provide timely clarity on this issue could exacerbate market apprehension.
After a sharp fall of over 40% in Ramkrishna Forgings' share price from its peak, further upside remains limited in the near term, according to UBS. With weak demand trends, limited visibility, and operational setbacks, the brokerage advocates a "wait-and-watch" approach, until a more favourable operating environment emerges.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.